Homeβ€ΊSearchβ€ΊEmerging Microbes and Infections

Emerging Microbes and Infections

Taylor and Francis Ltd. Β· United Kingdom Β· Est. 1968

ISSN2222-1751eISSN2222-1751
SJR Q1βœ“ WOS SCIEβœ“ Scopus / SJRβœ“ DOAJβœ“ Open Access
100
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
β—† WoS flagship (SCIE/SSCI/AHCI)78
βœ“ Corroboration (4 more)+22
Total100
Level data: Norwegian Register (HK-dir), NLOD 2.0. Β· Third-party records Β· how this is calculated Β· Report an error β†’
⚑ Speed vs Prestige
How does this journal balance review speed with impact level?
150
days submission β†’ published
measured Β· last 17 articles Β· accept 133d
20
weeks to publish Β· journal-reported
Average Β· vs ~15 wk median
Q1
SJR Rank
Top 25% in field
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (SCIE) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei
2.269
H-Indexi
131
CiteScore
ViewΒ β†—
Scopus metric Β· on the journal’s page
SNIPi
1.564
Total Worksi
2,520
Total Citationsi
100,834
2yr Mean Citednessi
6.20
Open Impact Factor alternative

Aims & Scope✦ Compiled from public sources

Emerging Microbes and Infections is a journal that disseminates information on microbes and infections, particularly those with increasing biological and clinical significance and pathogenic frequency. It covers topics such as vaccines, immune responses, epidemic surveillance, microbial infections, pathogens, clinical manifestation, diagnosis and management, cellular and molecular pathogenesis, and drug discovery.

AI-compiled from public web sources Β· verify on publisher page β†’

General Information

Country / RegionUnited Kingdom
Primary LanguageEnglish
1st Year Published1968
FrequencyMonthly
StatusActive (last: 2026)
Total Publications2,520
Publisher OrgTaylor & Francis
OA Since2011
Visit Journal Website

Submission Info

Peer ReviewSingle-blind
Review Time~20 weeks
Acceptance Rateβ€”
OA LicenseCC BY, CC BY-NC
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes
Plagiarism Detectionβœ“ Yes
πŸ“¦ Long-term Preservation
LOCKSSPorticoPMCCLOCKSS

Think.Check.Submit Compliance

10/12 Β· 83%
βœ…
Do you know the journal / publisher?
Taylor and Francis Ltd.
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
2222-1751 / 2222-1751
βœ…
Indexed in a trusted database?
WoS, Scopus, DOAJ, PubMed
βœ…
Peer review process documented?
Single-blind
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
βœ…
Long-term digital preservation?
LOCKSS, Portico, PMC, CLOCKSS
βœ…
Plagiarism detection in place?
Yes
βœ…
Listed in DOAJ (verified OA)?
DOAJ verified
βœ…
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
177
7.9k
2019
313
35k
2020
248
10k
2021
294
9.6k
2022
235
4.8k
2023
293
3.6k
2024
251
1k
2025
148
68
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

Drug DiscoveryQ1
EpidemiologyQ1
ImmunologyQ1
Infectious DiseasesQ1
Medicine (miscellaneous)Q1
MicrobiologyQ1
ParasitologyQ1
VirologyQ1

Subject Classification

Web of Science Categories

ImmunologyInfectious DiseasesMicrobiology

Scopus Categories

ImmunologyDrug DiscoveryVirologyMedicine (miscellaneous)Infectious DiseasesMicrobiologyEpidemiologyParasitology

Research Topics (OpenAlex)

SARS-CoV-2 and COVID-19 ResearchViral Infections and VectorsViral gastroenteritis research and epidemiologyInfluenza Virus Research StudiesMosquito-borne diseases and controlAnimal Disease Management and EpidemiologyCOVID-19 Clinical Research StudiesRespiratory viral infections researchAnimal Virus Infections StudiesViral Infections and Immunology Research

Frequently asked questions about Emerging Microbes and Infections

Is Emerging Microbes and Infections a predatory journal?

PubScope has no integrity flags on record for Emerging Microbes and Infections: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of Emerging Microbes and Infections?

Emerging Microbes and Infections is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 6.20.

Is Emerging Microbes and Infections indexed in Scopus and Web of Science?

Emerging Microbes and Infections is indexed in Web of Science, Scopus, DOAJ.

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref